Is FOXO4-DRI part of the fork head peptide family
sustained growth-hormone-axis stimulation also carries a theoretical, class-wide concern for worsened insulin resistance, a recognized effect of excess growth hormone exposure generally Evidence snapshot: The strongest available evidence is a small 1997 randomized, placebo-controlled human trial (19 adults aged 55-71) testing a closely related GHRH(1-29) analog over 16 weeks, which found increased IGF-1 in both sexes, a significant lean-mass increase in men only, and increased skin thickness in both sexes
the behavioral testing protocol has been described previously in detail (Wright et al
Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD
Chronic stress depletes glutathione
Glutathione and insulin are just two of the many intranasal compounds Parkinsons and Alzheimers researchers are checking out